MoneyWorks4Me

Venus Remedies informs about outcome of board meeting

13 Nov 2015 Evaluate

Venus Remedies has informed that the Board of Directors of the Company at its meeting held on November 13, 2015, has transacted the agenda item to reconsider the relevant date for preferential issue could not be discussed due to some approvals pending from exchanges.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..